The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Increased cardiac stromal cell-derived factor-1α (SDF-1α) expression promotes neovascularization and myocardial repair after ischemic injury through recruiting stem cells and reducing cardiomyocyte death. Previous studies have shown that heme oxygenase-1 and its reaction byproduct, carbon monoxide (CO), induce SDF-1α expression in ischemic heart. However, the mechanism underlying heme oxygenase-1/CO-induced cardiac SDF-1α expression remains elusive. This study aims to investigate the signaling pathway and the transcriptional factor that mediate CO-induced SDF-1α gene expression and cardioprotection. Approach and Results-CO gas and a CO-releasing compound, tricarbonyldichlororuthenium (II) dimer, dosedependently induced SDF-1α expression in primary neonatal cardiomyocytes and H9C2 cardiomyoblasts. Promoter luciferase-reporter assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation demonstrated that the activator protein 2α (AP-2α) mediated tricarbonyldichlororuthenium (II) dimer-induced SDF-1α gene transcription. Tricarbonyldichlororuthenium (II) dimer induced AP-2α expression via protein kinase B (AKT)-dependent signaling. AKT inhibition or AP-2α knockdown reduced tricarbonyldichlororuthenium (II) dimer-induced SDF-1α expression. Coronary ligation induced transient increases of cardiac AP-2α and SDF-1α expression, which were declined at 1 week postinfarction in mice. Periodic exposure of coronary-ligated mice to CO (250 ppm for 1 hour/day, 6 days) resumed the induction of AP-2α and SDF-1α gene expression in infarcted hearts. Immunohistochemistry and echocardiography performed at 4 weeks after coronary ligation revealed that CO treatment enhanced neovascularization in the myocardium of peri-infarct region and improved cardiac function. CO-mediated SDF-1α expression and cardioprotection was ablated by intramyocardial injection of lentivirus bearing specific short hairpin RNA targeting AP-2α. Conclusions-Our data demonstrate that AKT-dependent upregulation of AP-2α is essential for CO-induced SDF-1α expression and myocardial repair after ischemic injury. (Arterioscler Thromb Vasc Biol. 2013;33:785-794.) Key Words: activator protein 2α ◼ carbon monoxide ◼ heme oxygenase-1 ◼ ischemic heart ◼ stromal cell-derived factor-1α ◼ vascularization
T he recruitment of circulating bone marrow-derived stem and progenitor cells to ischemic tissues, and the participation of these cells in neovascularization contribute significantly to the repair process. Stromal cell-derived factor-1α (SDF-1α) is one of the key factors implicated in orchestrating stem/progenitor cell homing to injured tissues through interacting with chemokine (C-X-C motif) receptor-4 (CXCR4) receptor. 1, 2 It was previously shown that SDF-1α is transiently induced in ischemic heart. 3, 4 Blockade of SDF-1α/CXCR4 interactions markedly suppresses bone marrow-derived cell recruitment to the ischemic heart. 4 Conversely, administration or forced overexpression of SDF-1α in ischemic myocardium promotes stem/progenitor cell recruitment, and subsequent neovascularization and tissue regeneration. [4] [5] [6] [7] Furthermore, SDF-1α promotes cardiomyocyte survival against ischemic insults through paracrine or autocrine SDF-1α/CXCR4 axis. 6, 7 These findings support the therapeutic potential of SDF-1α in cardiac repair.
Heme oxygenase-1 (HO-1) is a stress-response enzyme catalyzing the oxidative degradation of heme to liberate free iron, carbon monoxide (CO), and biliverdin. 8 Earlier studies have shown that HO-1 exerts potent cardioprotective functions by reducing cardiomyocyte death and inflammatory reaction after myocardial ischemia/reperfusion via the antioxidant and anti-inflammatory effects of bilirubin and CO, respectively. [9] [10] [11] [12] [13] Recently, studies from our group and others also demonstrated that HO-1 promotes neovascularization in ischemic heart. [14] [15] [16] HO-1 and CO can induce the expressions of vascular endothelial growth factor and SDF-1α, which then promote the recruitment of circulating stem/progenitor cells for neovascularization. 14, 15 Nonetheless, the molecular mechanism underlying the regulation of SDF-1α gene expression by HO-1/ CO remains elusive. To this end, here we performed the in vitro experiments to investigate the signaling pathway and the downstream transcriptional factor responsible for CO-induced SDF-1α gene expression in primary cardiomyocytes and H9C2 cardiomyoblasts. We provide evidence indicating that the transcriptional factor, activator protein 2α (AP-2α), is upregulated after CO treatment through protein kinase B (AKT)-dependent signaling pathway and mediates SDF-1α gene expression. The involvement of AP-2α in CO-mediated cardioprotection in vivo was also confirmed by AP-2α gene knockdown experiments performed in mice with myocardial infarction (MI).
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

HO-1/CO Induces SDF-1α Expression
To confirm our previous finding that HO-1 overexpression promotes SDF-1α gene induction in myocardium in vivo, 14 we performed HO-1 gene transduction experiment in primary neonatal cardiomyocytes and H9C2 cardiomyoblasts. As shown in Figure 1A and 1B, when cells were infected with adenovirus bearing HO-1 gene for 48 hours, SDF-1α gene expression examined by quantitative real-time PCR was significantly higher, as compared with that of control cells without virus infection or cells infected with empty adenovirus. Cotreatment of H9C2 cells with a CO scavenger, hemoglobin (Hb; 100 µmol/L), resulted in a significant reduction of HO-1-induced SDF-1α gene expression ( Figure 1B ). Moreover, when H9C2 cells were exposed to CO gas or treated with a CO-releasing compound, tricarbonyldichlororuthenium (II) dimer (CORM-2), for 24 hours, SDF-1α gene expression was induced by CO (100 and 250 ppm) or CORM-2 (10-50 μmol/L) dose-dependently ( Figure 1C and 1D). Likewise, SDF-1α protein level was significantly increased in the culture media of CORM-2treated cells ( Figure IA in the online-only Data Supplement).
CO-Induced SDF-1α Expression Requires a New Protein Synthesis
Time course experiment revealed that SDF-1α mRNA and protein were significantly increased at 18 hours, reached a peak at 24 hours, and sustained up to 36 hours after CORM-2 treatment ( Figure 1E and Figure IB in the online-only Data Supplement). Treatment of cells with the protein synthesis inhibitor, cycloheximide (10 μmol/L), 17 resulted in a marked reduction of CORM-2-induced SDF-1α expression ( Figure  IIA in the online-only Data Supplement), suggesting that a new protein synthesis is required for CO-induced SDF-1α gene expression. Because CO can induce HO-1 expression in cardiomyocytes, 18 we then examined whether HO-1 is implicated in CORM-2-mediated effect. As shown in Figure Effect of heme oxygenase-1 (HO-1)/carbon monoxide (CO) on stromal cell-derived factor-1α (SDF-1α) gene expression. A, SDF-1α mRNA levels determined in primary neonatal cardiomyocytes receiving saline or indicated adenovirus vectors for 48 hours. *P<0.05 vs saline-treated group. B, SDF-1α mRNA levels determined in H9C2 cells receiving saline or indicated adenovirus vectors in the absence or presence of 100 µmol/L hemoglobin (Hb) for 48 hours. *P<0.01 vs salinetreated group; and † P<0.01 vs adenovirus bearing HO-1 gene (Adv-HO-1)-treated cells without Hb treatment. H9C2 cells were treated with indicated doses of CO gas (C) or tricarbonyldichlororuthenium (II) dimer (CORM-2) and inactive CORM-2 (50 μmol/L) (D) for 24 hours. *P<0.05 vs untreated control. E, H9C2 cells were treated with CORM-2 (50 μmol/L) for indicated times. *P<0.01 vs zero time point.
AKT Mediates CO-Induced SDF-1α Gene Expression
HO-1/CO induce p38 and AKT phosphorylation in cadiomyocytes. 19 As shown in Figure 2A , treatment of primary cardiomyocytes or H9C2 cells with AKT inhibitor, LY294002, but not by p38 inhibitor, SB203580, markedly suppressed CORM-2-induced SDF-1α gene expression. It has been shown that CO can promote reactive oxygen species (ROS) production via targeting mitochondrial complex IV or NADPH oxidase. 20 To examine whether ROS mediates the activation of AKT induced by CO or CORM-2 in myoblasts, the intracellular ROS levels in H9C2 cells treated with CO gas or CORM-2 were assessed by a redox-sensitive fluorescent dye, CM-H2DCFDA. As demonstrated in Figure IIIA in the onlineonly Data Supplement, CORM-2 and CO gas induced increase of ROS in H9C2 cells. Moreover, AKT phosphorylation induced by CORM-2 and CO gas was completely blocked by cotreatment with antioxidant (N-acetylcysteine; Figure   IIIB in the online-only Data Supplement), indicating that ROS mediated the effect of CO on AKT activation. To further confirm the role of AKT in SDF-1α gene expression, H9C2 cells were transfected with cDNA construct of hemagglutinintagged wild-type (WT)-AKT, constitutive active AKT (CA-AKT), or dominant negative AKT (DN-AKT) for 24 hours before treatment with or without CORM-2. As shown in Figure 2B , SDF-1α mRNA was substantially increased in cells overexpressing CA-AKT, but not WT-AKT or DN-AKT. CORM-2-induced SDF-1α expression was prominent in cells overexpressing WT-AKT and CA-AKT, but was suppressed in cells overexpressing DN-AKT. To explore the role of AKT signaling in the transcriptional regulation of SDF-1α gene in CORM-2-treated cells, H9C2 cells were transiently transfected with a luciferase reporter plasmid bearing the rat SDF-1α gene promoter region -547 to +30 relative to the transcriptional initiation site before CORM-2 treatment. As shown in Figure  2C , CORM-2 treatment increased luciferase activity by 3-fold, Figure 2 . AKT signaling mediates carbon monoxide (CO)-induced stromal cell-derived factor-1α (SDF-1α) gene transcription. A, Primary neonatal cardiomyocytes and H9C2 cells were treated with dimethyl sulfoxide (DMSO) or tricarbonyldichlororuthenium (II) dimer (CORM-2; 50 μmol/L) in the absence or presence of 20 μmol/L of LY294002 or SB203580 as indicated for 24 hours, then SDF-1α mRNA levels were assessed. *P<0.01 vs DMSO-treated cells; and † P<0.01 vs cells treated with CORM-2 alone. B, H9C2 cells were transfected with hemagglutinin -tagged wild-type (WT)-AKT, constitutive active AKT (CA-AKT), or dominant negative AKT (DN-AKT) construct as indicated for 24 hours, followed by treatment with DMSO or CORM-2 (50 μmol/L) for 24 hours. SDF-1α mRNA levels were then determined. *P<0.01 vs DMSO-treated cells transfected with WT-AKT; and † P<0.01 vs CORM-2-treated cells transfected with WT-AKT. C, H9C2 cells were transfected with a luciferase reporter driven by rat SDF-1α promoter (-547 to +30) for 24 hours, then incubated with DMSO or CORM-2 (50 μmol/L) in the absence or presence of the indicated inhibitors (20 μmol/L) for 18 hours before luciferase activity measurement. *P<0.01 vs DMSO-treated control. D, H9C2 cells were transfected with luciferase promoter construct together with WT-AKT, CA-AKT, or DN-AKT construct as indicated for 24 hours, followed by treatment with DMSO or CORM-2 for 18 hours before luciferase activity assay. *P<0.01 vs DMSO-treated cells transfected with WT-AKT; and † P<0.01 vs CORM-2-treated cells transfected with WT-AKT.
which was attenuated by cotreatment with LY2944002, but not SB203580. The basal SDF-1α promoter activity was significantly increased in cells transfected with CA-AKT construct, but not WT-AKT or DN-AKT construct ( Figure 2D ), whereas CORM-2-induced SDF-1α promoter activity was markedly reduced by cotransfection with DN-AKT construct, but not WT-AKT or CA-AKT ( Figure 2D ).
Localization of CO-Regulatory Element in SDF-1α Gene Promoter
To identify the cis-regulatory element responsible for CO effect, cells were transfected with a series of promoter deletion constructs. It was shown that CORM-2-induced luciferase activity was still observed in construct with region -245 to +30, but no longer in shorter construct with region -86 to +30, indicating that the region -245 to -86 contains the CO-responsive element ( Figure 3A ). The computational analysis revealed 3 potential binding sites for AP-2α, including ggCCTCggC (-192/-184), gCCggggAC (-173/-165), and gCCgAgggC(-164/-156), within this region. To confirm the importance of these AP-2α-binding sites, we prepared the promoter constructs with mutations in each of these sites for the promoter assay. As shown in Figure 3B , CORM-2induced luciferase activity of (-245/+30) construct was not significantly affected by the mutations at -192/-184, but partially reduced by the mutations at either -173/-165 or -164/-156 site. When these 2 adjacent AP-2α-binding sites were mutated, CORM-2-induced luciferase activity was completely abolished, indicating that these 2 sites are required to mediate CORM-2-induced SDF-1 gene transcription.
CO Induces AP-2α Expression Through AKT Activation
We then performed experiment to investigate whether CORM-2 induces AP-2α expression. As shown in Figure 3C , CORM-2 induced a significant increase of AP-2α mRNA, which was prominent at 6 hours, reached a peak at 12 hours, and then returned to basal level at 24 hours in H9C2 cells. Western blot analysis revealed a similar time course of AP-2α protein expression in CORM-2-treated cells ( Figure 3D and Figure IVA in the online-only Data Supplement). Additional experiment demonstrated that CORM-2 failed to induce the expression of hypoxia-inducible factor-1α (HIF-1α; Figure V in the online-only Data Supplement), which has been shown to induce SDF-1α gene expression. 21 Experiment was then performed to assess whether AP-2α expression is mediated by AKT activation. Overexpression of hemagglutinintagged CA-AKT, but not WT-AKT or DN-AKT, significantly increased AP-2α mRNA and protein expression levels in H9C2 cells ( Figure 3E and 3F and Figure IVB 
Role of AP-2α in CO-Induced SDF-1α Gene Expression
To examine whether CO induces an increased AP-2α binding to SDF-1 promoter in vivo, we performed the chromatin immunoprecipitation assay in H9C2 cells. In parallel with an increased AP-2α protein expression, CORM-2 induced AP-2α binding to SDF-1α promoter containing the -173/-156 sequence ( Figure 4A ). To confirm the importance of AP-2α in SDF-1α promoter activation and gene expression, H9C2 cells were transfected with specific small interfering RNA targeting AP-2α. As shown in Figure 4B and 4C, CORM-induced AP-2α expression was markedly reduced. Concomitantly, CORM-2-induced SDF-1α promoter activation and gene expression was substantially suppressed ( Figure 4D and 4E) . In contrast, transfection with control small interfering RNA had no effect on increased SDF-1α promoter activity and SDF-1 gene expression in CORM-2-treated cells. 
CO Promotes AP-2α/SDF-1α Expressions in Ischemic Heart
To investigate whether AP-2α has a role in SDF-1α expression in ischemic heart, we examined the expressions of AP-2α and SDF-1α in hearts of C57BL/6J mice subjected to coronary ligation. As shown in Figure 5A , significant increases of AP-2α and SDF-1α expressions were detected at day 2, peaked at day 4, and then declined at day 7, after the induction of MI. To explore whether CO can resume AP-2α and SDF-1α gene inductions after their declines in the ischemic heart, C57BL/6J mice with coronary ligation for a week were exposed to 250 ppm CO gas for 1 hour per day for 6 consecutive days. As shown in Figure VIA and VIB in the online-only Data Supplement, coronary ligation resulted in increased AKT phosphorylation in hearts, which was further enhanced by CO treatment. Likewise, both mRNA and protein levels of cardiac AP-2α and SDF-1α determined at the end of the last CO exposure were significantly higher as compared with those of untreated counterparts ( Figure 5B and Figures VIC, VID, and VIIIA in the online-only Data Supplement). When we performed the immunostaining on heart sections with antibody against c-kit, the marker for progenitor cells, the results showed that coronary ligation resulted in significant recruitment of c-kit + cells to the infarcted heart ( Figure VIIA and VIIB in the online-only Data Supplement). CO treatment further promoted the recruitment of these cells. Figure 5 . Carbon monoxide (CO) inhalation promotes activator protein 2α (AP-2α)/stromal cell-derived factor-1α (SDF-1α) expression and myocardial repair. A, B6 mice were subjected to sham operation (0 day) or coronary ligation for indicated days. The hearts were collected and AP-2α and SDF-1α mRNA levels were determined (n=4/group). *P<0.02 vs sham-operated group. B, B6 mice were subjected to sham operation (n=10) or coronary ligation (n=20) for a week. Ten of the infarcted mice were exposed to 250 ppm CO gas for 1 hour per day for 6 days. Immunostaining performed with antibodies against Gr-1 and CD11b, the markers for neutrophils and macrophages, respectively, revealed that CO treatment significantly reduced the infiltration of these inflammatory cells in the infarcted hearts ( Figure VIIC -VIIF in the online-only Data Supplement). When the cardiac functions of the infarcted mice were assessed at 4 weeks post-MI, the results showed that MI-induced ventricular dilatation and functional impairment were significantly attenuated by the short-term periodic CO treatment ( Figure 5C and Table I in the online-only Data Supplement). Consistently, histological examination of the heart sections revealed that the infarct size and fibrotic area were much smaller in CO-treated infarcted mice as compared with untreated counterparts (Figure 5D-5F) . Immunostaining experiment performed with a specific antibody against CD31, an endothelial marker, demonstrated higher vascular density in the peri-infarcts of CO-treated mice ( Figure 5G and 5H) . The cardioprotective effect was also observed in mice receiving 6 days of intravenous administration of CORM-2 (4 mg/kg of body weight) starting at the second week after the coronary ligation ( Figure IX 
AP-2α Knockdown Ablates CO-Induced Cardioprotection
To investigate the role of AP-2α in CO-induced SDF-1α expression and cardiac protection post-MI, we performed the in vivo gene knockdown experiment using lentivirus bearing specific short hairpin RNA (shRNA) targeting AP-2α (AP-2α shRNA). We first examined the lentivirus-mediated gene knockdown efficiency in vivo using lentivirus bearing specific shRNA targeting lamin A/C. When animals were subjected to intramyocardial injection of the negative control ((-)shRNA) or lamin A/C-shRNA lentivirus (1×10 9 virus particles/mouse) for 7 days, the lamin A/C expression in the ventricular tissues of mice treated with lamin A/C-shRNA lentivirus was significantly reduced as compared with control counterparts ( Figure XI in the online-only Data Supplement). We also examined the infection efficiency of lentivirus in infarcted heart using the lentivirus bearing green fluorescent protein construct. When the animal was subjected to coronary ligation, followed by the injection of the green fluorescent proteinlentivirus (1×10 9 virus particles) at 5 different sites around the peri-infarct region for 7 days, the green fluorescent protein expression was evident in the myocardium of the peri-infarct region ( Figure XII in the online-only Data Supplement). We then performed the experiments by injecting the (-)shRNA or AP-2α shRNA lentivirus around the peri-infarct region of coronary ligated mice. After 1 week, each treated group of mice was randomly divided into 2 subgroups with 1 subgroup remaining in normal air condition and another subgroup of mice being exposed to periodic CO gas treatment as described above. As shown in Figure 6A and 6B, CO-induced AP-2α protein expression in the ventricular tissues of the infarcted mice was significantly reduced in mice treated with AP-2α shRNA, but not with (-)shRNA. In parallel, CO-induced SDF-1α mRNA ( Figure 6C ) and protein ( Figure  VIIIB in the online-only Data Supplement) expressions were also abolished in mice treated with AP-2α shRNA. Echocardiography examination of these mice at 4 weeks after MI revealed that the beneficial effect of CO on the ventricular dilatation and the cardiac performance was diminished in the group receiving AP-2α shRNA treatment ( Figure 6D and Table II in the online-only Data Supplement). Likewise, the reduced infarct size and fibrosis observed in CO-treated infarcted mice were attenuated by AP-2α shRNA treatment ( Figure 6E and 6F) . AP-2α knockdown also abolished the enhanced neovascularization in CO-treated mice ( Figure 6G ). However, the suppressive effect of CO on the inflammatory cell infiltration in infarcted heart was not significantly affected by AP-2α knockdown ( Figure XIII in the online-only Data Supplement).
Discussion
SDF-1α plays a crucial role in tissue repair after ischemic injury. However, the transient expression of SDF-1α observed after the induction of MI is not sufficient for myocardial repair. [3] [4] [5] [6] Increasing our understanding of the mechanism underlying the regulation of SDF-1α expression in cardiomyocytes will lay the ground for translational research that results in better treatment of ischemic heart disease. Hypoxia has been shown to induce SDF-1α expression through the activation of HIF-1α, 21 which is believed to participate in the upregulation of SDF-1α in the ischemic heart. However, the potential involvement of other signaling pathways and transcriptional factors in the regulation of cardiac SDF-1α expression has not been fully explored. We previously reported that HO-1 overexpression in ischemic heart promotes SDF-1α gene expression, which then promotes neovascularization in infarcted mice. 14 The involvement of HO-1 in the regulation of SDF-1α expression was further substantiated by the observation that the level of transient cardiac SDF-1α gene expression post-MI is much lower in HO-1 -/mice than in WT mice. 14 These findings support that HO-1 can induce SDF-1α expression under normoxia condition. Here, we showed that CO mediates HO-induced SDF-1α gene expression in cardiomyocytes and H9C2 cardiomyoblasts in vitro. Notably, CO-induced SDF-1α expression required a new protein synthesis. This observation may explain the late induction of SDF-1α expression, which was not evident until 18 hours after CO treatment. Although CO has been shown to exert beneficial effect on several disease settings by inducing HO-1 expression, 18, 22, 23 our data showed that HO-1 is not required for CO-induced SDF-1 expression and cardioprotection. Nevertheless, considering that HO-1 can exert cardioprotective effects via multiple pathways, [8] [9] [10] [11] [12] [13] the possibility for CO-induced HO-1 to act together with CO to confer further protection in the infarcted heart cannot be completely ruled out. Moreover, HIF-1α has been shown to regulate SDF-1α expression after vascular injury under normoxia condition. 24 Studies by others have also shown that CO can increase the stabilization and translational stimulation of HIF-1α in macrophages and astrocytes. 25, 26 However, we did not detect significant increase in HIF-1α level in CO-treated H9C2 cells, indicating that the effect of CO on HIF-1α expression is cell type-specific and unlikely responsible for SDF-1α gene induction in the present context. By performing SDF-1α gene promoter assay, we identified 2 adjacent AP-2α-binding sites in the proximal promoter region of SDF-1α gene as the cis-regulatory element responsible for CO-induced SDF-1α promoter activation. Chromatin immunoprecipitation assay also revealed the increase of AP-2α protein binding to the SDF-1α gene promoter after CO treatment. Moreover, AP-2α expression was significantly induced by CO via AKT-dependent pathway. Additional experiment demonstrated that CORM-2 and CO gas induced an increase of intracellular ROS, which mediated AKT activation in myoblasts. This observation was consistent with previous findings by others. 20, 27 The functional importance of AKT-AP-2α axis in SDF-1α gene expression again was evidenced by the experiment showing that AKT inhibition or small interfering RNAmediated AP-2α gene knockdown significantly reduced CO-induced SDF-1α promoter activity and SDF-1α gene expression, whereas overexpression of CA-AKT or AP-2α was sufficient to induce SDF-1α gene transcription in H9C2 cells. Collectively, these results support the role of ROS/ AKT signaling in sequential expression of AP-2α and SDF-1α in CORM-2/CO-treated myoblasts.
AP-2α is a member of the helix-span-helix transcription factors implicated in proliferation and differentiation of various cell types during development. 28 AP-2α expression Figure 6 . Lentivirus-mediated activator protein 2α (AP-2α) knockdown abrogates carbon monoxide (CO)-induced stromal cell-derived factor-1α (SDF-1α) gene expression and cardiac repair. B6 mice underwent coronary ligation and received intramyocardial injection of saline or lentivirus bearing negative short hairpin RNA ((-) shRNA) or specific shRNA targeting AP-2α (AP-2α shRNA) in the infarct borders (n=20/group). A, After 1 week, each treated group of mice was randomly divided into 2 subgroups with 1 subgroup periodically exposed to CO gas (250 ppm, 1 hour/day) for 6 days. After the last CO treatment, 5 mice from each subgroup were euthanized. AP-2α protein expression level was determined by Western blot analysis. Data shown are the representative results of 3 mice in each group. B, AP-2α protein levels were quantified by densitometry. *P<0.02 vs sham group; and † P<0.05 vs CO-treated control group. C, SDF-1α mRNA levels in ventricular tissues determined. *P<0.01 vs normal air-treated group infected with same lentivirus; and † P<0.01 vs CO-treated control group. D, At 4 weeks, the cardiac functions of the remaining mice were assessed by echocardiography. The quantitative results on left ventricular internal dimension (LVID) and fraction shortening (FS) were determined. *P<0.01 vs normal air-treated group infected with same lentivirus; and † P<0.01 vs CO-treated control group. After animals were euthanized, the infarct sizes (E), collagen content (F), and vascular densities (G) in various treated groups were assessed. *P<0.05 vs normal air-treated group infected with same lentivirus; and † P<0.05 vs CO-treated control group.
is predominant in the developing embryo, and its deficiency results in the defects of cranial closure and craniofacial development. 28 Severe cardiac outflow tract malformation was also seen in AP-2α-deficient embryos. 29 AP-2α can function either as a transcriptional activator or repressor. 30 Studies have shown that AP-2α is highly induced in various cancers and has a role in tumorigenesis. [30] [31] [32] [33] However, little is known about its role in cardiovascular diseases. Similar to the time course of SDF-1α expression, AP-2α was highly induced within the first few days and then returned to basal level at 7 days after the induction of MI. When we exposed mice that were subjected to coronary ligation for a week to a periodic CO exposure for 6 days, the expression levels of both AP-2α and SDF-1α in the ischemic hearts were significantly resumed. Moreover, the echocardiography performed at 4 weeks after the induction of MI revealed that the cardiac performance was much improved in CO-treated mice, which was associated with increased neovascularization in the infarcted hearts of the same group of mice. Consistent with the present finding, an early study also showed that treatment with CO donor alleviates cardiac remodeling in infarcted mice. 16 To further confirm that the AP-2α-mediated SDF-1α gene induction is crucial to CO-induced cardioprotection, we performed the in vivo gene knockdown experiment in coronary-ligated mice. The results showed that CO-induced AP-2α, as well as SDF-1α expressions were significantly reduced in mice receiving the myocardial administration of lentivirus bearing AP-2α-shRNA, but not lentivirus bearing control shRNA. Likewise, functional and pathohistological assessments revealed that CO-mediated cardiac repair was substantially attenuated by AP-2α knockdown. These results provide the convincing evidence in support of the importance of AP-2α-mediated SDF-1α gene transcription in CO-induced cardioprotection after MI. It is apparent that CO confers cardioprotection via its proangiogenic and antiinflammatory effects. Notably, AP-2α knockdown attenuated enhanced neovascularization but had no effect on the reduction of inflammatory cells in CO-treated infarcted heart, indicating that the proangiogenic and anti-inflammatory effects of CO are mediated by distinct pathways. Our data showed that attenuation of neovascularization significantly hampered CO-mediated cardioprotection even in the condition that the inflammatory reaction remained suppressed. These observations highlight the importance of enhanced neovascularization in cooperation with reduced inflammation in cardiac repair post-MI.
The importance of SDF-1α/CXCR4 axis in myocardial repair is well documented. Nevertheless, a recent study using CXCR4 heterozygous mice has revealed the double-edged role of SDF-1α/CXCR4 axis in the recruitment of both inflammatory and progenitor cells post-MI. 34 Although the infarct size was reduced in CXCR4 +/mice compared with WT mice as a result of the attenuation of acute recruitment of inflammatory cells, the ventricular function was not improved in these mice because of the decreased neovascularization and coronary flow recovery after MI. 34 Apparently, a therapeutic strategy that can modulate a temporal activation SDF-1α/ CXCR4 axis after the acute inflammatory phase would provide better outcomes. Our findings suggest the possibility of using CO for the timely induction of SDF-1α to treat ischemic heart disease.
